Skip to main content

Find Clinical Trials

Home
Conditions
Inflammatory Bowel Diseases

Clinical trial condition

Inflammatory Bowel Diseases

Explore clinical trials studying Inflammatory Bowel Diseases. Study availability and eligibility vary by location and protocol.

1,522 public trials 288 recruiting studies

Refine in advanced search Browse all conditions

Inflammatory Bowel Diseases trial results

Not Yet Recruiting

AppenDectomy Vs ANti TNF-a in Inducing Clinical and EnDoscopic Remission in Left-sided Ulcerative Colitis

NCT05931458

Conditions: Colitis, Colitis, Ulcerative, Colonic Diseases, +6 more
Locations: Not specified

View Trial Details

Not Yet Recruiting

HLADQA1*05 Genotype and the Efficacy of Treatment With Infliximab in Chinese Population Crohn's Disease

NCT05813860

Conditions: Crohn Disease, Digestive System Diseases, Gastroenteritis, +4 more
Locations: Not specified

View Trial Details

Not Yet Recruiting

Preoperative Nutrition for Crohn's Disease Patients

NCT04398836

Conditions: Crohn Disease, Digestive System Diseases, Gastroenteritis, +6 more
Locations: Dep. of Gastroenterology, Tel Aviv Sourasky Medical Center Tel Aviv, Israel

View Trial Details

Completed

A Study of Ustekinumab in Pediatric Participants With Moderately to Severely Active Crohn's Disease

NCT04673357

Conditions: Crohn Disease, Digestive System Diseases, Gastroenteritis, +3 more
Locations: Nemours DuPont Hospital for Children Wilmington, Delaware, United States

Children's Center for Digestive Health Care Atlanta, Georgia, United States

Mayo Clinic Rochester, Minnesota, United States

Morristown Memorial Hospital Morristown, New Jersey, United States

View all 53 locations

View Trial Details

Completed

A Phase 2a Safety and Efficacy Open-Label Study of Tulisokibart (MK-7240/PRA023) in Participants With Moderately to Severely Active Crohn's Disease (MK-7240-006)

NCT05013905

Conditions: Crohn Disease, Digestive System Diseases, Gastroenteritis, +3 more
Locations: Prometheus Biosciences Selected Site Los Angeles, California, United States

Prometheus Biosciences Selected Site Los Angeles, California, United States

Prometheus Biosciences Selected Site Liberty, Kansas, United States

Prometheus Biosciences Selected Site Chesterfield, Michigan, United States

View all 37 locations

View Trial Details

Completed

GI Permeability Change in Response to Aquamin®

NCT04855799

Conditions: Colitis, Colitis, Ulcerative, Colonic Diseases, +8 more
Locations: University of Michigan Hospital Ann Arbor, Michigan, United States

View Trial Details

Completed

Effectiveness and Safety of Mirikizumab in Patients With Moderate-to-severe Ulcerative Colitis: a Real-life Retrospective Multicenter Study

NCT07695636

Conditions: Colitis, Colitis, Ulcerative, Colonic Diseases, +6 more
Locations: IRCCS San Raffaele Milan, Mi, Italy

View Trial Details

Completed

PDA001 for the Treatment of Adults With Moderate-to-Severe Crohn's Disease

NCT01155362

Conditions: Crohn Disease, Crohn's Disease, Digestive System Diseases, +4 more
Locations: Cedars Sinai Medical Center Los Angeles, California, United States

University of California, Irvine Orange, California, United States

Yale School of Medicine Digestive Diseases New Haven, Connecticut, United States

University of Florida Gainesville, Florida, United States

View all 13 locations

View Trial Details

Completed

Specified Drug-Use Survey on Vedolizumab for IV Infusion 300 mg [Crohn's Disease]

NCT04002180

Conditions: Crohn Disease, Crohn's Disease, Digestive System Diseases, +4 more
Locations: Takeda Selected Site Tokyo, Japan

View Trial Details

Completed

Loss of RESponse to Ustekinumab Treated by Dose Escalation

NCT04245215

Conditions: Crohn Disease, Digestive System Diseases, Gastroenteritis, +3 more
Locations: Ingrid Arijs Zaventem, Belgium

View Trial Details